Ayşe Ercan

774 total citations
29 papers, 626 citations indexed

About

Ayşe Ercan is a scholar working on Molecular Biology, Cancer Research and Organic Chemistry. According to data from OpenAlex, Ayşe Ercan has authored 29 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Organic Chemistry. Recurrent topics in Ayşe Ercan's work include Cancer, Lipids, and Metabolism (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). Ayşe Ercan is often cited by papers focused on Cancer, Lipids, and Metabolism (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). Ayşe Ercan collaborates with scholars based in Türkiye, Iran and Spain. Ayşe Ercan's co-authors include Meltem Müftüoğlu, Nesrin Kartal Özer, Gülberk Uçar, Özlem Dalmızrak, Mutlu Dilsiz Aytemir, Bülent Elibol, Turgay Dalkara, Venkatesan Jayaprakash, Barij Nayan Sinha and Gamze Varan and has published in prestigious journals such as International Journal of Pharmaceutics, Journal of Pharmaceutical Sciences and Movement Disorders.

In The Last Decade

Ayşe Ercan

29 papers receiving 614 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ayşe Ercan Türkiye 14 206 154 139 78 73 29 626
Qian Yu China 19 544 2.6× 111 0.7× 127 0.9× 33 0.4× 61 0.8× 67 1.1k
Fu-Chuo Peng Taiwan 17 250 1.2× 72 0.5× 40 0.3× 41 0.5× 47 0.6× 46 820
María Benlloch Spain 18 493 2.4× 70 0.5× 64 0.5× 24 0.3× 110 1.5× 50 1.0k
Neeraj Tiwari India 11 181 0.9× 54 0.4× 110 0.8× 69 0.9× 87 1.2× 23 570
Daniela Pantano Italy 11 193 0.9× 128 0.8× 26 0.2× 45 0.6× 133 1.8× 11 618
Sarah L. Miles United States 14 308 1.5× 35 0.2× 127 0.9× 32 0.4× 74 1.0× 27 723
E. Srinivasan India 11 199 1.0× 33 0.2× 206 1.5× 73 0.9× 140 1.9× 35 492
Pamela Nardiello Italy 11 209 1.0× 133 0.9× 24 0.2× 43 0.6× 148 2.0× 14 718
Longjian Huang China 13 250 1.2× 30 0.2× 70 0.5× 50 0.6× 91 1.2× 29 652

Countries citing papers authored by Ayşe Ercan

Since Specialization
Citations

This map shows the geographic impact of Ayşe Ercan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayşe Ercan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayşe Ercan more than expected).

Fields of papers citing papers by Ayşe Ercan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayşe Ercan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayşe Ercan. The network helps show where Ayşe Ercan may publish in the future.

Co-authorship network of co-authors of Ayşe Ercan

This figure shows the co-authorship network connecting the top 25 collaborators of Ayşe Ercan. A scholar is included among the top collaborators of Ayşe Ercan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayşe Ercan. Ayşe Ercan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sotto, Antonella Di, Tuba Tüylü Küçükkılınç, Ayşe Ercan, et al.. (2024). 4‐{3‐[(Pyridin‐4‐ylmethyl)amino]‐[1,2,4]triazolo[4,3‐b][1,2,4]triazin‐6‐yl}phenol: An improved anticancer agent in hepatocellular carcinoma and a selective MDR1/MRP modulator. Archiv der Pharmazie. 357(6). e2300704–e2300704. 1 indexed citations
2.
Varan, Gamze, et al.. (2022). A different approach to immunochemotherapy for colon Cancer: Development of nanoplexes of cyclodextrins and Interleukin-2 loaded with 5-FU. International Journal of Pharmaceutics. 623. 121940–121940. 17 indexed citations
3.
Erkekoğlu, Pınar, et al.. (2022). Effects of single or combined exposure to bisphenol A and mono(2-ethylhexyl)phthalate on oxidant/antioxidant status, endoplasmic reticulum stress, and apoptosis in HepG2 cell line. Environmental Science and Pollution Research. 30(5). 12189–12206. 14 indexed citations
4.
Varan, Cem, et al.. (2022). Pharmacometabolomic assessment of vitamin E loaded human serum albumin nanoparticles on HepG2 cancer cell lines. Journal of Drug Delivery Science and Technology. 79. 104017–104017. 4 indexed citations
5.
Ercan, Ayşe, Mustafa Çelebi̇er, Gamze Varan, et al.. (2021). Polycationic cyclodextrin nanoparticles induce apoptosis and affect antitumoral activity in HepG2 cell line: An evaluation at the molecular level. International Journal of Pharmaceutics. 598. 120379–120379. 7 indexed citations
6.
7.
Erdoğar, Nazlı, et al.. (2020). Q-TOF LC/MS-based Untargeted Metabolomics Approach to Evaluate the Effect of Folate-Conjugated Cyclodextrins on Triple-Negative Breast Cancer Cells. Current Pharmaceutical Analysis. 17(10). 1272–1281. 2 indexed citations
8.
Ercan, Ayşe, et al.. (2020). An allomaltol derivative triggers distinct death pathways in luminal a and triple-negative breast cancer subtypes. Bioorganic Chemistry. 105. 104403–104403. 5 indexed citations
9.
Ercan, Ayşe, et al.. (2019). Synthesis, computational molecular docking analysis and effectiveness on tyrosinase inhibition of kojic acid derivatives. Bioorganic Chemistry. 88. 102950–102950. 60 indexed citations
10.
Ercan, Ayşe, et al.. (2019). HGF-1 proliferation on titanium dental implants treated with laser melting technology. Nigerian Journal of Clinical Practice. 22(2). 251–251. 7 indexed citations
11.
Aytemir, Mutlu Dilsiz, et al.. (2019). A kojic acid derivative promotes intrinsic apoptotic pathway of hepatocellular carcinoma cells without incurring drug resistance. Chemical Biology & Drug Design. 94(6). 2084–2093. 13 indexed citations
12.
Ercan, Ayşe, et al.. (2018). Global omics strategies to investigate the effect of cyclodextrin nanoparticles on MCF-7 breast cancer cells. European Journal of Pharmaceutical Sciences. 123. 377–386. 6 indexed citations
13.
Ercan, Ayşe, et al.. (2018). Synthesis and Cytotoxic Evaluation of Kojic Acid Derivatives with Inhibitory Activity on Melanogenesis in Human Melanoma Cells. Anti-Cancer Agents in Medicinal Chemistry. 18(15). 2137–2148. 31 indexed citations
14.
Saka, Mendane, Perim Fatma Türker, Ayşe Ercan, Gül Kızıltan, & Murat Baş. (2014). Is neck circumference measurement an indicator for abdominal obesity? A pilot study on Turkish Adults. African Health Sciences. 14(3). 570–570. 41 indexed citations
15.
Yabanoğlu, Samiye, Ayşe Ercan, Gülberk Uçar, et al.. (2011). Pyrazoline based MAO inhibitors: Synthesis, biological evaluation and SAR studies. Bioorganic & Medicinal Chemistry Letters. 21(14). 4296–4300. 38 indexed citations
16.
17.
Gökhan-Kelekçi, Nesrin, Ömer Şimşek, Ayşe Ercan, et al.. (2009). Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors. Bioorganic & Medicinal Chemistry. 17(18). 6761–6772. 33 indexed citations
18.
Jayaprakash, Venkatesan, Barij Nayan Sinha, Gülberk Uçar, & Ayşe Ercan. (2008). Pyrazoline-based mycobactin analogues as MAO-inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(24). 6362–6368. 52 indexed citations
19.
Müftüoğlu, Meltem, Bülent Elibol, Özlem Dalmızrak, et al.. (2003). Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations. Movement Disorders. 19(5). 544–548. 182 indexed citations
20.
Özer, Nesrin Kartal, et al.. (1999). Simple, high-yield purification of xanthine oxidase from bovine milk. Journal of Biochemical and Biophysical Methods. 39(3). 153–159. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qian Yu Breakdown of academic impact, for papers by Fu-Chuo Peng Breakdown of academic impact, for papers by María Benlloch Breakdown of academic impact, for papers by Neeraj Tiwari Breakdown of academic impact, for papers by Daniela Pantano Breakdown of academic impact, for papers by Sarah L. Miles Breakdown of academic impact, for papers by E. Srinivasan Breakdown of academic impact, for papers by Pamela Nardiello Breakdown of academic impact, for papers by Longjian Huang
Rankless by CCL
2026